Delivery Order SPE2DB24D1107-SPE2DB25FZEB2

Award Date 1/9/25
Potential Completion Date 1/10/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,589.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humalog 100 unit/mL vial (10 mL), a medication used to treat diabetes. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at...
This federal contract award, valued at $1,990.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Humalog 100 unit/ml vial (10 ml) to support federal government healthcare programs, particularly military and veterans' healthcare. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award, valued at $1,554.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humalog 100 unit/mL vial, a 10 mL insulin medication, with a completion date of August 6, 2021. The award is not designated as a set-aside contract. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.40 firm fixed-price delivery order is for the supply of Humalog 100 Unit/mL vial, a medication used to treat diabetes. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support...
This federal contract award, valued at $3,281.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Humalog 100 unit/mL vials, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order, with a completion date of December 6, 2024. Amerisourcebergen, a for-profit organization, is the prime contractor, and there is no set-aside designation mentioned. This contract...
This federal contract award, valued at $1,365.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 unit/ml vial 10ml. The contract has a ceiling value of $1,381.72 and was awarded on August 11, 2021, with an ultimate completion date of August 12, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.86 firm fixed-price delivery order is for the supply of Humalog 100 Unit/ML vials, a medication used to treat diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,366.20 Firm Fixed Price contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a diabetes medication. This is a Delivery Order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.96 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 8, 2023 and was awarded on May 5, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB25FZEB2
    Delivery Order

This federal contract award, valued at $1,413.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Humalog 100 Unit/mL vial 10mL, a medication used for diabetes management.

The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/10/25, 11:30 AM